Orbimed Advisors Llc - Jun 30, 2025 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX)

Filing Manager: Orbimed Advisors Llc
Reporting Manager: OrbiMed Advisors LLC
Security: CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: CTMX
Shares outstanding: 157M shares
Disclosed Ownership: 8.46M shares
Ownership: 5.4%
Form type: SCHEDULE 13G
Date filed: 8/14/2025, 06:07 PM
Date of event: Jun 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
OrbiMed Advisors LLC	5.4%	8.46M	0	8.46M	/s/ Carl L. Gordon	Carl L. Gordon / Member of OrbiMed Advisors LLC